BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31128357)

  • 1. Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy.
    Wilkie JR; Mierzwa ML; Yao J; Eisbruch A; Feng M; Weyburne G; Chen X; Holevinski L; Mayo CS
    Radiother Oncol; 2019 Aug; 137():167-174. PubMed ID: 31128357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
    Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
    Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
    [No Abstract]   [Full Text] [Related]  

  • 3. Electronic Patient-Reported Outcome Measures in Radiation Oncology: Initial Experience After Workflow Implementation.
    Hauth F; Bizu V; App R; Lautenbacher H; Tenev A; Bitzer M; Malek NP; Zips D; Gani C
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12345. PubMed ID: 31342906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
    van der Laan HP; Van den Bosch L; Schuit E; Steenbakkers RJHM; van der Schaaf A; Langendijk JA
    Radiother Oncol; 2021 Jul; 160():47-53. PubMed ID: 33892023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease.
    Taarnhøj GA; Johansen C; Lindberg H; Basch E; Dueck A; Pappot H
    Cancer Med; 2020 May; 9(9):3078-3087. PubMed ID: 32154663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
    Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
    Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires.
    Steen-Olsen EB; Stormoen DR; Kristensen CA; Vogelius IR; Holländer-Mieritz C; Pappot H
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4199-4206. PubMed ID: 35357578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
    Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
    Sapir E; Tao Y; Feng F; Samuels S; El Naqa I; Murdoch-Kinch CA; Feng M; Schipper M; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):354-361. PubMed ID: 27473816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
    Sandler KA; Mitchell SA; Basch E; Raldow AC; Steinberg ML; Sharif J; Cook RR; Kupelian PA; McCloskey SA
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):44-52. PubMed ID: 30102201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    Verma V; Simone CB; Mishra MV
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer.
    Christodoulou M; McCloskey P; Stones N; Bayman N; Burt P; Chittalia A; Harris M; Lee L; Pemberton L; Sheikh H; Swindell R; Faivre-Finn C
    Radiother Oncol; 2014 Aug; 112(2):244-9. PubMed ID: 25107555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer.
    Long SM; Singh A; Tin AL; O'Hara B; Cohen MA; Lee N; Pfister DG; Hung T; Wong RJ; Vickers AJ; Estilo CL; Cracchiolo JR
    JAMA Otolaryngol Head Neck Surg; 2022 Aug; 148(8):749-755. PubMed ID: 35737363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
    ; Kamal M; Rosenthal DI; Volpe S; Goepfert RP; Garden AS; Hutcheson KA; Al Feghali KA; Meheissen MAM; Eraj SA; Dursteler AE; Williams B; Smith JB; Aymard JM; Berends J; White AL; Frank SJ; Morrison WH; Cardoso R; Chambers MS; Sturgis EM; Mendoza TR; Lu C; Mohamed ASR; Fuller CD; Gunn GB
    Radiother Oncol; 2018 Jan; 126(1):75-80. PubMed ID: 29229507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity.
    Barbosa da Silva JL; Doty RL; Miyazaki JVMK; Borges R; Pinna FR; Voegels RL; Fornazieri MA
    Oral Oncol; 2019 Aug; 95():115-119. PubMed ID: 31345378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.
    Kakoei S; Haghdoost AA; Rad M; Mohammadalizadeh S; Pourdamghan N; Nakhaei M; Bahador M
    Arch Iran Med; 2012 Apr; 15(4):214-8. PubMed ID: 22424038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
    Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
    Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study.
    Thor M; Olsson CE; Oh JH; Hedström J; Pauli N; Johansson M; Deasy JO; Finizia C
    Clin Otolaryngol; 2018 Feb; 43(1):22-30. PubMed ID: 28463432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.